The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Mutation analysis ofPEX7 in 60 probands with rhizomelic chondrodysplasia punctata and functional correlations of genotype with phenotype
Open accessAbstract
PEX7 encodes the cytosolic receptor for the set of peroxisomal matrix enzymes targeted to the organelle by the peroxisome targeting signal 2 (PTS2). Mutations in PEX7 cause rhizomelic chondrodysplasia punctata (RCDP), a distinct peroxisome biogenesis disorder. In previous work we described three novel PEX7 mutant alleles, including one, L292X, with a high frequency due to a founder effect. We have now extended our analysis to 60 RCDP probands and identified a total of 24 PEX7 alleles, accounting for 95% of the mutant PEX7 genes in our sample. Of these, 50% are L292X, 13% are IVS9+1G>C, and the remainder are mostly private. IVS9+1G>C occurs on at least three different haplotypes and thus appears to result from recurrent mutation. The phenotypic spectrum of RCDP is broader than commonly recognized and includes minimally affected individuals at the mild end of the spectrum. To relate PEX7 genotype and phenotype, we evaluated the consequence of the disease mutation on PEX7 RNA by Northern analysis and RT/PCR. We evaluated the function of the encoded Pex7 protein (Pex7p) by expressing selected alleles in fibroblasts from RCDP patients and assaying their ability to restore import of a PTS2 marker protein. We find that residual activity of mutant Pex7p and reduced amounts of normal Pex7p are associated with milder and variant phenotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The severity of the disease varies remarkably, depending strongly on the residual activity of the affected enzyme and, thus, the level of plasmalogens [188–191].”
From Peroxisomes in brain development and function (2016) · cites this paper as [190]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabolic and molecular bases of inherited disease
Chen, Y.-T. (2001) · Medical Entomology and Zoology · Cited by 6,928
Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs
Kozak, M. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.2.857 · Cited by 3,259
Shapiro, M. B., & Senapathy, P. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.17.7155 · Cited by 2,313
The ancient regulatory-protein family of WD-repeat proteins
Neer, E. J., Schmidt, C. J., Nambudripad, R., & Smith, T. F. (1994) · Nature · doi:10.1038/371297a0 · Cited by 1,491
Frameshift Mutations and the Genetic Code
Streisinger, G., Okada, Y., Emrich, J., Newton, J., Tsugita, A., Terzaghi, E., & Inouye, M. (1966) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1966.031.01.014 · Cited by 1,400 · cited 1×
“The wild-type PEX7 sequence in this region has a tandem repeat, GGACGCC G GGACGCC from bp 38–52, and thus the mechanism generating the duplication and deletion alleles is consistent with a slipped-mispairing model [Streisinger et al., 1966].”
The WD repeat: a common architecture for diverse functions
Smith, T. F., Gaitatzes, C. G., Saxena, K., & Neer, E. J. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01384-5 · Cited by 1,256
The structure of the G protein heterotrimer Giα1β1γ2
Wall, M. A., Coleman, D. E., Lee, E. N., Iñiguez-Lluhı́, J. A., Posner, B. A., Gilman, A. G., & Sprang, S. R. (1995) · Cell · doi:10.1016/0092-8674(95)90220-1 · Cited by 1,140
A conserved tripeptide sorts proteins to peroxisomes.
Gould, S. J., Keller, G. A., Hosken, N. A., Wilkinson, J. Q., & Subramani, S. E. (1989) · The Journal of Cell Biology · doi:10.1083/jcb.108.5.1657 · Cited by 1,107
Crystal structure of a GA protein βγdimer at 2.1 Å resolution
Sondek, J., Bohm, A., Lambright, D. G., Hamm, H. E., & Sigler, P. B. (1996) · Nature · doi:10.1038/379369a0 · Cited by 761
Association of a human G-protein β3 subunit variant with hypertension
Siffert, W., Rosskopf, D., Siffert, G., Busch, S., Moritz, A., Erbel, R., Sharma, A. M., Ritz, E., Wichmann, H. ‐., Jakobs, K. H., et al. (1998) · Nature Genetics · doi:10.1038/ng0198-45 · Cited by 726
Research works printed but not linked: 4
- Chakraborty, 2001, AJHG, 69S
- Cheng, 1994, Mol Cell Biol, 14, 6317, 10.1128/MCB.14.9.6317 · DOI
- Moser, 1996, AJHG, 59S
- Moser, 1997, Ann Neurol, 42
Cited by
Sorted by citations
Functions of plasmalogen lipids in health and disease
Braverman, N. E., & Moser, A. B. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.05.008 · Cited by 1,082
Self-citationCalvo, S. E., Pagliarini, D. J., & Mootha, V. K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810916106 · Cited by 914
Gene Expression Regulation by Upstream Open Reading Frames and Human Disease
Barbosa, C., Peixeiro, I., & Romão, L. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003529 · Cited by 525
Peroxisome biogenesis disorders
Steinberg, S. J., Dodt, G., Raymond, G. V., Braverman, N. E., Moser, A. B., & Moser, H. W. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.09.010 · Cited by 522
Self-citationUsing Whole-Exome Sequencing to Identify Inherited Causes of Autism
Yu, T. W., Chahrour, M. H., Coulter, M. E., Jiralerspong, S., Okamura-Ikeda, K., Ataman, B., Schmitz-Abe, K., Harmin, D. A., Adli, M., Malik, A. N., et al. (2013) · Neuron · doi:10.1016/j.neuron.2012.11.002 · Cited by 442
Self-citationFunctions and biosynthesis of plasmalogens in health and disease
Brites, P., Waterham, H. R., & Wanders, R. J. A. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2003.12.010 · Cited by 430
Genetics and molecular basis of human peroxisome biogenesis disorders
Waterham, H. R., & Ebberink, M. S. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.04.006 · Cited by 283
Peroxisomal disorders: The single peroxisomal enzyme deficiencies
Wanders, R. J. A., & Waterham, H. R. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.08.010 · Cited by 279
Metabolic functions of peroxisomes in health and disease
Wanders, R. J. A. (2013) · Biochimie · doi:10.1016/j.biochi.2013.08.022 · Cited by 232
The physiological functions of human peroxisomes
Wanders, R. J. A., Baes, M., Ribeiro, D., Ferdinandusse, S., & Waterham, H. R. (2023) · Physiological Reviews · doi:10.1152/physrev.00051.2021 · Cited by 228
Peroxisomal disorders I: biochemistry and genetics of peroxisome biogenesis disorders
Wanders, R. J. A., & Waterham, H. R. (2004) · Clinical Genetics · doi:10.1111/j.1399-0004.2004.00329.x · Cited by 220
Peroxisomes, lipid metabolism, and peroxisomal disorders
Wanders, R. J. A. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.08.016 · Cited by 205
Peroxisome Biogenesis Disorders
Grønborg, S. W., Gould, S. J., & Valle, D. L. (2003) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.4.070802.110424 · Cited by 204
Self-citationPeroxisomes in brain development and function
Berger, J., Dorninger, F., Forss-Petter, S., & Kunze, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.12.005 · Cited by 194
Plasmalogens and Chronic Inflammatory Diseases
Bozelli, J. C., Azher, S., & Epand, R. M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.730829 · Cited by 182
The Diverse Genetic Landscape of Neurodevelopmental Disorders
Hu, W. F., Chahrour, M. H., & Walsh, C. A. (2014) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090413-025600 · Cited by 177
Identification of PEX7 as the second gene involved in Refsum disease
van den Brink, D. M., Brites, P., Haasjes, J., Wierzbicki, A. S., Mitchell, J., Lambert-Hamill, M., de Belleroche, J., Jansen, G. A., Waterham, H. R., & Ronald Wanders, J. A. (2003) · The American Journal of Human Genetics · doi:10.1086/346093 · Cited by 171
Metabolic and molecular basis of peroxisomal disorders: A review
Wanders, R. J. A. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20661 · Cited by 170
Peroxisomes, lipid metabolism and lipotoxicity
Wanders, R. J. A., Ferdinandusse, S., Brites, P., & Kemp, S. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.01.001 · Cited by 169
Dorninger, F., Forss‐Petter, S., & Berger, J. (2017) · FEBS Letters · doi:10.1002/1873-3468.12788 · Cited by 165
Peroxisome biogenesis disorders: Biological, clinical and pathophysiological perspectives
Braverman, N., D’Agostino, D., & MacLean, G. E. (2013) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.1113 · Cited by 162
Self-citationEbberink, M. S., Mooijer, P. A. W., Gootjes, J., Koster, J., Wanders, R. J. A., & Waterham, H. R. (2010) · Human Mutation · doi:10.1002/humu.21388 · Cited by 159
Phytanic acid: production from phytol, its breakdown and role in human disease
van den Brink, D. M., & Wanders, R. J. A. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5463-y · Cited by 134
AHI1 mutations cause both retinal dystrophy and renal cystic disease in Joubert syndrome
Parisi, M. A., Doherty, D., Eckert, M. L., Shaw, D. W. W., Ozyurek, H., Aysun, S., Giray, O., Swaid, A. A., Shahwan, S. A., Dohayan, N., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.036608 · Cited by 133
Buchert, R., Tawamie, H., Smith, C., Uebe, S., Innes, A. M., Al Hallak, B., Ekici, A. B., Sticht, H., Schwarze, B., Lamont, R. E., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.10.003 · Cited by 132
Jansen, G. A., Waterham, H. R., & Wanders, R. J. A. (2004) · Human Mutation · doi:10.1002/humu.10315 · Cited by 127
Alkyl-Glycerol Rescues Plasmalogen Levels and Pathology of Ether-Phospholipid Deficient Mice
Brites, P., Ferreira, A. S., da Silva, T. F., Sousa, V., Malheiro, A. R., Durán, M., Waterham, H. R., Baes, M. I., & Wanders, R. J. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028539 · Cited by 132
Peroxisome biogenesis disorders
Argyriou, C., D’Agostino, D., & Braverman, N. (2016) · Translational Science of Rare Diseases · doi:10.3233/trd-160003 · Cited by 129
Self-citationKunze, M., & Berger, J. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00259 · Cited by 119
Brites, P. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg236 · Cited by 116
Honsho, M., & Fujiki, Y. (2017) · FEBS Letters · doi:10.1002/1873-3468.12743 · Cited by 105
Dorninger, F., Brodde, A., Braverman, N., Moser, A. B., Just, W. W., Forss‐Petter, S., Brügger, B., & Berger, J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.11.005 · Cited by 102
Self-citationThe genetic nomenclature of recessive cerebellar ataxias
Rossi, M., Anheim, M., Dürr, A., Klein, C., Koenig, M., Synofzik, M., Marras, C., van de Warrenburg, B. P. C., & on behalf of the International Parkinson and Movement Disorder Society Task Force on Classification and Nomenclature of Genetic Movement Disorders (2018) · Movement Disorders · doi:10.1002/mds.27415 · Cited by 99
CRISPR-free, programmable RNA pseudouridylation to suppress premature termination codons
Song, J., Dong, L., Sun, H., Luo, N., Huang, Q., Li, K., Shen, X., Jiang, Z., Lv, Z., Peng, L., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.11.011 · Cited by 92
Clinical diagnosis, biochemical findings and MRI spectrum of peroxisomal disorders
Poll-The, B. T., & Gärtner, J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.03.011 · Cited by 85
The importance of ether-phospholipids: A view from the perspective of mouse models
da Silva, T. F., Sousa, V., Malheiro, A. R., & Brites, P. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.05.014 · Cited by 89
Barøy, T., Koster, J., Strømme, P., Ebberink, M. S., Misceo, D., Ferdinandusse, S., Holmgren, A., Hughes, T., Merckoll, E., Westvik, J., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv305 · Cited by 81
Itzkovitz, B., Jiralerspong, S., Nimmo, G. A. M., Loscalzo, M. L., Horovitz, D. D. G., Snowden, A., Moser, A. B., Steinberg, S., & Braverman, N. (2011) · Human Mutation · doi:10.1002/humu.21623 · Cited by 78
Self-citationThe chemical biology of branched-chain lipid metabolism
Mukherji, M., Schofield, C. J., Wierzbicki, A. S., Jansen, G. A., Wanders, R. J. A., & Lloyd, M. D. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00016-x · Cited by 77
Hoover-Fong, J. E., Sobreira, N. L. D. M., Jurgens, J. A., Modaff, P., Zawatsky, C. L. B., Moser, A. B., Kim, O.-H., Cho, T., Cho, S. Y., Kim, S. J., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.11.018 · Cited by 70
Self-citationThe type-2 peroxisomal targeting signal
Kunze, M. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.118609 · Cited by 68
A Pex7 hypomorphic mouse model for plasmalogen deficiency affecting the lens and skeleton
Braverman, N., Zhang, R., Chen, L., Nimmo, G., Scheper, S., Tran, T., Chaudhury, R., Moser, A., & Steinberg, S. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2009.12.005 · Cited by 66
Self-citationCrystal structure of peroxisomal targeting signal-2 bound to its receptor complex Pex7p–Pex21p
Pan, D., Nakatsu, T., & Kato, H. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2618 · Cited by 65
Dranchak, P. K., Pietro, E. D., Snowden, A., Oesch, N., Braverman, N., Steinberg, S. J., & Hacia, J. G. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22979 · Cited by 62
Self-citationThe neurology of rhizomelic chondrodysplasia punctata
Bams-Mengerink, A. M., Koelman, J. H., Waterham, H., Barth, P. G., & Poll-The, B. T. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-174 · Cited by 59
Mukai, S., & Fujiki, Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607178200 · Cited by 59
Reis, L. M., & Semina, E. V. (2018) · Human Genetics · doi:10.1007/s00439-018-1932-x · Cited by 61
Structural Requirements for Interaction of Peroxisomal Targeting Signal 2 and Its Receptor PEX7
Kunze, M., Neuberger, G., Maurer‐Stroh, S., Ma, J., Eck, T., Braverman, N., Schmid, J. A., Eisenhaber, F., & Berger, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.301853 · Cited by 52
Self-citationThe important role of biochemical and functional studies in the diagnostics of peroxisomal disorders
Ferdinandusse, S., Ebberink, M. S., Vaz, F. M., Waterham, H. R., & Wanders, R. J. A. (2016) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-016-9922-4 · Cited by 51
ASK1 and MAP2K6 as modifiers of age at onset in Huntington’s disease
Arning, L., Monté, D., Hansen, W., Wieczorek, S., Jagiello, P., Akkad, D. A., Andrich, J., Kraus, P. H., Carsten Saft, C., & Epplen, J. T. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0299-6 · Cited by 50
Ataluren—Promising Therapeutic Premature Termination Codon Readthrough Frontrunner
Michorowska, S. (2021) · Pharmaceuticals · doi:10.3390/ph14080785 · Cited by 49
Fallatah, W., Smith, T. M., Cui, W., Jayasinghe, D., Pietro, E. D., Ritchie, S. A., & Braverman, N. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.042499 · Cited by 43
Self-citationMechanistic Insights into PTS2-mediated Peroxisomal Protein Import
Kunze, M., Malkani, N., Maurer-Stroh, S., Wiesinger, C., Schmid, J. A., & Berger, J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.601575 · Cited by 40
Liegel, R., Chang, B., Dubielzig, R., & Sidjanin, D. J. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.02.002 · Cited by 38
Tissue-selective alteration of ethanolamine plasmalogen metabolism in dedifferentiated colon mucosa
Lopez, D. H., Bestard-Escalas, J., Garate, J., Maimó‐Barceló, A., Fernández, R., Reigada, R., Khorrami, S., Ginard, D., Okazaki, T., Fernández, J. A., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.04.017 · Cited by 38
Phenotype of adult Refsum disease due to a defect in peroxin 7
Horn, M. A., van den Brink, D. M., Wanders, R. J. A., Durán, M., Poll‐The, B. T., Tallaksen, C. M. E., Stokke, O., Moser, H., & Skjeldal, O. H. (2007) · Neurology · doi:10.1212/01.wnl.0000255960.01644.39 · Cited by 38
Self-citationMizuno, Y., Ninomiya, Y., Nakachi, Y., Iseki, M., Iwasa, H., Akita, M., Tsukui, T., Shimozawa, N., Ito, C., Toshimori, K., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003286 · Cited by 37
Human and great ape red blood cells differ in plasmalogen levels and composition
Moser, A. B., Steinberg, S. J., Watkins, P. A., Moser, H. W., Ramaswamy, K. A., Siegmund, K. D., Lee, D. R., Ely, J. J., Ryder, O. A., & Hacia, J. G. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-101 · Cited by 37
Self-citationFallatah, W., Schouten, M., Yergeau, C., Pietro, E. D., Engelen, M., Waterham, H. R., Poll‐The, B. T., & Braverman, N. (2020) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12349 · Cited by 34
Self-citationBiase, I. D., Tortorelli, S., Kratz, L. E., Steinberg, S. J., Cusmano‐Ozog, K. P., & Braverman, N. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0713-9 · Cited by 35
Self-citationMalheiro, A. R., da Silva, T. F., & Brites, P. (2015) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9795-3 · Cited by 33
Rhizomelic Chondrodysplasia Punctata Type 1
Braverman, N., Moser, A. B., & Steinberg, S. J. (2012) · Europe PMC (PubMed Central) · Cited by 29
Self-citationQian, G., Fan, W., Ahlemeyer, B., Karnati, S., & Baumgart‐Vogt, E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143439 · Cited by 32
Rhizomelic chrondrodysplasia punctata type 2 resulting from paternal isodisomy of chromosome 1
Nimmo, G. A. M., Monsonego, S., Descartes, M. D., Franklin, J. C., Steinberg, S. J., & Braverman, N. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33489 · Cited by 28
Self-citationMetabolic neuropathies and myopathies
D’Amico, A., & Bertini, E. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59565-2.00013-7 · Cited by 28
Growth charts for individuals with rhizomelic chondrodysplasia punctata
Duker, A. L., Niiler, T., Eldridge, G., Brereton, N. H., Braverman, N., & Bober, M. B. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37961 · Cited by 27
Self-citationWiese, S., Gronemeyer, T., Brites, P., Ofman, R., Bunse, C., Renz, C., Meyer, H. E., Wanders, R. J. A., & Warscheid, B. (2011) · International Journal of Mass Spectrometry · doi:10.1016/j.ijms.2011.09.005 · Cited by 23
Das, Y., Swinkels, D., & Baes, M. I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084101 · Cited by 24
Liegel, R. P., Ronchetti, A., & Sidjanin, D. J. (2014) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2014.06.003 · Cited by 25
da Silva, T. F., Granadeiro, L., Bessa‐Neto, D., Luz, L. L., Safronov, B. V., & Brites, P. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.102123 · Cited by 22
Rhizomelic chondrodysplasia punctata morbidity and mortality, an update
Duker, A. L., Niiler, T., Kinderman, D., Schouten, M., Poll‐The, B. T., Braverman, N., & Bober, M. B. (2019) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.61413 · Cited by 21
Self-citationKawada, Y., Khan, M., Sharma, A. K., Ratnayake, D. B., Dobashi, K., Asayama, K., Moser, H. W., Contreras, M. A., & Singh, I. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.07.012 · Cited by 16
Self-citationLuisman, T., Smith, T. M., Ritchie, S. A., & Malone, K. E. (2021) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-01889-z · Cited by 15
Congenital heart defects common in rhizomelic chondrodysplasia punctata
Duker, A. L., Eldridge, G., Braverman, N., & Bober, M. B. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37404 · Cited by 14
Self-citationRo, M., Park, J., Nam, M., Bang, H. J., Yang, J.-W., Choi, K.-S., Kim, S. K., Chung, J., & Kwack, K. (2012) · Journal of Child Neurology · doi:10.1177/0883073811435507 · Cited by 14
Phenotypic Variability (Heterogeneity) of Peroxisomal Disorders
Mandel, H., & Korman, S. H. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9072-3_2 · Cited by 14
Asymmetric Distribution of Plasmalogens and Their Roles—A Mini Review
Honsho, M., & Fujiki, Y. (2023) · Membranes · doi:10.3390/membranes13090764 · Cited by 14
Fallatah, W., Cui, W., Pietro, E. D., Carter, G. T., Pounder, B., Dorninger, F., Pifl, C., Moser, A. B., Berger, J., & Braverman, N. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.886316 · Cited by 14
Self-citationRhizomelic chondrodysplasia punctata type 1: report of mutations in 3 children from India
Phadke, S. R., Gupta, N., Girisha, K. M., Kabra, M., Maeda, M., Vidal, E., Moser, A. B., Steinberg, S. J., Puri, R. D., Verma, I. C., et al. (2010) · Journal of Applied Genetics · doi:10.1007/bf03195717 · Cited by 11
Self-citationAli, M., Khan, S. Y., Rodrigues, T. A., Francisco, T., Jiao, X., Qi, H., Kabir, F., Irum, B., Rauf, B., Khan, A. A., et al. (2021) · Human Genetics · doi:10.1007/s00439-020-02238-z · Cited by 9
Zwijnenburg, P. J. G., Deurloo, K. L., Waterham, H. R., Meijers-Heijboer, E. J., van Vugt, J. M. G., & Tan-Sindhunata, G. M. B. (2009) · Prenatal Diagnosis · doi:10.1002/pd.2425 · Cited by 9
Nanetti, L., Pensato, V., Leoni, V., Rizzetto, M., Caccia, C., Taroni, F., Mariotti, C., & Gellera, C. (2015) · Journal of Clinical Neurology · doi:10.3988/jcn.2015.11.2.197 · Cited by 9
Smith, T. M., Knudsen, K. J., & Ritchie, S. A. (2025) · Clinical and Translational Science · doi:10.1111/cts.70195 · Cited by 8
Wu, Y., Deng, Y., Angelov, B., & Angelova, A. (2025) · FASEB BioAdvances · doi:10.1096/fba.2025-00010 · Cited by 10
Peroxisomal Localization of a Truncated HMG-CoA Reductase under Low Cholesterol Conditions
Wang, J., Kunze, M., Villoria-González, A., Weinhofer, I., & Berger, J. (2024) · Biomolecules · doi:10.3390/biom14020244 · Cited by 8
Multiple Lab Comparison of Microarray Platforms
Irizarry, R. A. (2004) · Collection of Biostatistics Research Archive · Cited by 8
Peroxisomal Disorders and Neurological Disease
Braverman, N., & Eichler, F. (2009) · Elsevier eBooks · doi:10.1016/b978-008045046-9.02011-8 · Cited by 7
Self-citationBraverman, N., Argyriou, C., & Moser, A. B. (2014) · Springer eBooks · doi:10.1007/978-3-7091-1788-0_4 · Cited by 7
Self-citationBiase, I. D., Yuzyuk, T. N., Cui, W., Zuromski, L. M., Moser, A. B., & Braverman, N. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117295 · Cited by 5
Self-citationChondrodysplasia Punctata 1, X-Linked
Braverman, N., Bober, M. B., Brunetti‐Pierri, N., & Oswald, G. L. (2014) · Cited by 4
Self-citationRhizomelic Chondrodysplasia Punctata Type 1 Caused by a Novel Mutation in the PEX7 Gene
Çim, A., Coşkun, S., Görükmez, O., Yüksel, H., Uluca, Ü., Pietro, E. D., Plourde, F., & Braverman, N. (2015) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.1835 · Cited by 4
Self-citationRaymond, G. V., Watkins, P. A., Steinberg, S. J., & Powers, J. (2009) · Springer eBooks · doi:10.1007/978-0-387-30378-9_26 · Cited by 4
Mohamadynejad, P., Ghaedi, K., Shafeghati, Y., Salamian, A., Tanhaie, S., Karamali, F., Rabiee, F., Parivar, K., Baharvand, H., & Nasr‐Esfahani, M. H. (2013) · Gene · doi:10.1016/j.gene.2013.01.022 · Cited by 4
Poll‐The, B. T., Aubourg, P. R., & Wanders, R. J. A. (2011) · Springer eBooks · doi:10.1007/978-3-642-15720-2_41 · Cited by 4
Inborn Errors of Non-Mitochondrial Fatty Acid Metabolism Including Peroxisomal Disorders
Wanders, R. J. A., Engelen, M., & Vaz, F. M. (2022) · Springer eBooks · doi:10.1007/978-3-662-63123-2_42 · Cited by 4
Clinical features and genetic analysis of A20 haploinsufficiency
Xue, F., An, C., Lei, Z., Dong, S., Guo, Y., Hou, J., Yu, J., & Wang, Y. (2025) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-025-04004-8 · Cited by 3
Yardımcı-Lokmanoğlu, B. N., Mutlu, A., & Livanelioğlu, A. (2020) · Physical & Occupational Therapy In Pediatrics · doi:10.1080/01942638.2020.1841870 · Cited by 3
Masih, S., Moirangthem, A., & Phadke, S. R. (2021) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62110 · Cited by 3
Simpson, C. L., Wojciechowski, R., Ibay, G. P., Stambolian, D., & Wilson, J. (2011) · PubMed Central · Cited by 3
Bertolesi, G. E., Chilije, M. F. J., Li, V., Thompson, C. C., López‐Villalobos, A., Hehr, C. L., Atkinson‐Leadbeater, K., Zaremberg, V., & McFarlane, S. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.5.17 · Cited by 3
Metadata
- Authors
- Braverman, N., Chen, L., Lin, P., Obie, C., Steel, G., Douglas, P., Chakraborty, P. K., Clarke, J. T. R., Boneh, A., Moser, A., Moser, H., & Valle, D.
- Affiliations
- Johns Hopkins University (US)
- Howard Hughes Medical Institute (US)
- Hospital for Sick Children (CA)
- Royal Children's Hospital (AU)
- Kennedy Krieger Institute (US)
- Corresponding author
- Braverman, Nancy
- Venue
- Human Mutation
- Publisher
- Hindawi Limited
- Published
- 2002-09-24
- Volume
- 20
- Issue
- 4
- Pages
- 284-297
- ISSN
- 1059-7794 (ISSN-L)
- 1098-1004
- OpenAlex
- W1987179081
- Cited by
- 134
- References
- 52
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 2 · 2023: 4 · 2022: 5 · 2021: 8 · 2020: 2 · 2019: 7 · 2018: 4 · 2017: 4 · 2016: 5 · 2015: 8 · 2014: 11 · 2013: 11 · 2012: 10
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Human Mutation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Johns Hopkins University
- National Institutes of Health
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (1RO1HD39747, P01HD10981, P01HD010981, R01HD039747)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- PEX7, rhizomelic chondrodysplasia punctata, peroxisome biogenesis disorders, founder effect, genotype-phenotype correlation, peroxisomal matrix protein import, haplotypes
- MeSH terms
- Peroxisomal Targeting Signal 2 Receptor, Adolescent, Amino Acid Sequence, Child, Child, Preschool, DNA Mutational Analysis, Genotype, Humans, Male, Middle Aged, Molecular Sequence Data, Mutation, Phenotype, Receptors, Cytoplasmic and Nuclear, Founder Effect, Chondrodysplasia Punctata, Rhizomelic, Amino Acid Substitution, Protein Structure, Quaternary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review